Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Greenock Telegraph
greenocktelegraph.co.uk > news > 26529930.new-unit-childrens-hospital-molly-cuddihys-name

New palliative care unit for children to be set up in memory of Gourock campaigner

2+ hour, 15+ min ago   (694+ words) A GROUND-BREAKING new unit to care for children with terminal illnesses is to be set up in the name of incredible Gourock campaigner Molly Cuddihy a year after her death. Molly's Suite is a palliative care hub to be created…...

Mirage News
miragenews.com > enhertu-shows-14-3-month-pfs-in-her2-lung-1743475

Enhertu Shows 14.3-Month PFS in HER2+ Lung Cancer Trial

2+ hour, 23+ min ago   (338+ words) Results were presented today during the Presidential Symposium at the IASLC 2026 World Conference on Lung Cancer (#WCLC26) hosted by the International Association for the Study of Lung Cancer in Seoul, South Korea (abstract #PL03.08). In the primary endpoint of PFS, Enhertu monotherapy…...

Hellocare
hellocare.com.au > holistic-palliative-care-is-in-the-conversations-of-dying-well

Holistic palliative care is in the conversations of dying well

5+ hour, 26+ min ago   (1807+ words) Vandersman didn’t come to palliative care from arm’s length. It was her top pick. “Palliative care was my first choice in my RN graduate program, other staff were astonished, ‘you could have done theatre or ICU?’” “In the culture I…...

@ASBMB
asbmb.org > asbmb-today > people > 091426 > lillian-brady-receives-mcknight-scholar-award

Lillian Brady receives McKnight Scholar Award

2+ hour, 29+ min ago   (287+ words) Lillian Brady was selected to receive a 2026 McKnight Scholar Award from The McKnight Endowment Fund for Neuroscience. The award recognizes early-career scientists who are establishing independent research programs and advancing neuroscience. The McKnight Scholar Awards have supported innovative neuroscience investigators…...

Google News
miragenews.com > tagrisso-achieves-8-year-survival-in-egfr-lung-1743462

Tagrisso Achieves 8-Year Survival in EGFR Lung Cancer

2+ hour, 37+ min ago   (499+ words) These results were presented today during the Presidential Symposium at the IASLC 2026 World Conference on Lung Cancer (#WCLC26) hosted by the International Association for the Study of Lung Cancer in Seoul, Republic of Korea (Abstract PL03.01). These data were also simultaneously published…...

European Medical Journal
emjreviews.com > oncology > article > interview-felix-guerrero-ramos

Félix Guerrero-Ramos on Bladder Cancer Advances

1+ week, 2+ day ago   (653+ words) EMJ This site is intended for healthcare professionals Félix Guerrero-Ramos on Bladder Cancer Advances Félix Guerrero-Ramos | Oncologic Urology Unit Coordinator, Department of Urology, Hospital Universitario 12 de Octubre, Madrid; Co-founder, Danae Urogenomics, Madrid, Spain What first drew you to uro-oncology and,…...

sedona.biz
sedona.biz > neuro-oncology-why-ai-agents-of-openai-anthropic-could-cure-cancer-by-dec-2030

AI Agents Could Cure Cancer by Dec 2030 via Nerve Targeting

5+ hour, 46+ min ago   (1475+ words) By David Stephen “neurons and nerves — via a variety of mechanisms that researchers are still teasing apart — seem to regulate almost everything about cancer, from tumor initiation in many cases to tumor growth, tumor invasion and metastasis, probably resistance to…...

WBAP
wbap.com > 09/14/2026 > 101591

Susan G Komen Race for the Cure

2+ hour, 34+ min ago   (24+ words) WBAP - Sat & Sun 3am-4am, 5am-6am This Morning with Gordon Deal Susan G Komen Race for the Cure...

MarketScreener
marketscreener.com > news > otsuka-arm-s-lung-cancer-drug-plus-chemotherapy-trial-shows-six-month-median-pfs-benefit-ce785bdcd88cf32d

Otsuka Arm's Lung Cancer Drug Plus Chemotherapy Trial Shows Six-Month Median PFS Benefit

2+ hour, 37+ min ago   (41+ words) marketscreener.com Otsuka Holdings Co., Ltd. Otsuka Arm's Lung Cancer Drug Plus Chemotherapy Trial Shows Six-Month Median PFS Benefit Published on 09/14/2026 at 01:08 am EDT...

The Asia Business Daily
asiae.co.kr > en > article > bio-health > 2026091413410388821

Yuhan Corporation Unveils Clinical Trial for Oral HER2-Targeted Therapy...Potential Efficacy for Brain Metastases Expected

3+ hour, 4+ min ago   (456+ words) Published 14 Sep.2026 13:41(KST) Yuhan Corporation has disclosed the clinical phase 1/2 trial design and the current progress for its oral HER2-targeted therapy candidate, YH42946. The company plans to secure initial clinical results by the end of this year, determine the recommended dose,…...